Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
09/1996
09/10/1996CA2171081A1 Use of 6,7-substitute-2-aminotetralines for preparing pharmaceutical compositions useful for the treatment of septic shock, and antipyretic and antiinflammatory pharmaceutical compositions
09/06/1996WO1996027018A1 A plasmid for expressing modified recombinant proteins in a bacterial system
09/06/1996WO1996027009A1 Human amine transporter
09/06/1996WO1996027007A1 A novel growth factor and a genetic sequence encoding same
09/06/1996WO1996026961A2 Peptidyl compounds comprising an itim motif which regulate hematopoietic function and their use
09/06/1996WO1996026956A1 Protein phosphatase inhibitor
09/06/1996WO1996026935A1 2-benzyl-3-arylbenzothiophenes
09/06/1996WO1996026932A1 2-arylbenzazole compounds
09/06/1996WO1996026738A1 Pharmaceutical compositions for controlled release of soluble receptors
09/06/1996WO1996026736A1 Vascular endothelial growth factor-b
09/06/1996WO1996026730A1 Use of acid-sensitive organo- transition metal compounds in cancer treatment
09/06/1996WO1996026720A1 Pharmaceutical compositions comprising monoamine oxidase b inhibitors
09/06/1996WO1996026716A1 Elcatonin controlled release microsphere formulation for treatment of osteoporosis
09/06/1996WO1996026712A2 Use of angiogenesis suppressors for inhibiting hair growth
09/06/1996WO1996026705A1 Reduction of hair growth
09/06/1996WO1996021655A3 Substituted oxazolidine calpain and/or cathepsin b inhibitors
09/06/1996WO1996020690A3 3,3-(disubstituted)cyclohexan-1-ylidine acetate monomers and related compounds
09/06/1996WO1996020209A3 14α,17α-C2-BRIDGED 19-NOR-PROGESTERONE DERIVATIVES
09/06/1996WO1996018372A3 Cationic amphiphiles and plasmids for intracellular delivery of therapeutic molecules
09/06/1996WO1996016981A3 Peptide compounds for prevention and/or treatment of no-mediated diseases
09/06/1996CA2247207A1 Peptidyl compounds comprising an itim motif which regulate hematopoietic function and their use
09/06/1996CA2214134A1 2-benzyl-3-arylbenzothiophenes
09/06/1996CA2213734A1 A plasmid for expressing modified recombinant proteins in a bacterial system
09/06/1996CA2213344A1 Use of acid-sensitive organo-transition metal compounds in cancer treatment
09/04/1996EP0729964A1 Phosphorous-containing benzothiophenes
09/04/1996EP0729956A1 Benzothiophene compounds, intermediates, compositions, and methods
09/04/1996EP0729955A1 2-Benzyl-3-Arylbenzothiophenes useful for the treatment of post-menopausal syndrome
09/04/1996EP0729954A1 Substituted thiophene sulfonyl ureas and thioureas, process for their preparation, their use as medicaments
09/04/1996EP0729951A1 Naphthyl compounds, intermediates, compositions, and methods
09/04/1996EP0729758A2 Pyrazolopyrimidines and pyrrolopyrimidines for treatment of neuronal and other disorders
09/04/1996EP0729750A1 Use of an interleukin-1 antagonist and/or alpha-TNF antagonist in a cosmetic, pharmaceutical or dermatological composition, and the composition therefrom, possibly used in combination with a histamine antagonist
09/04/1996EP0729749A1 Pharmaceutical compositions containing dinoreburnamenine derivatives
09/04/1996EP0729472A1 Piperidinylcamphorsulfonyl oxytocin antagonists
09/04/1996EP0729468A1 Non-peptide tachykinin receptor antagonists
09/04/1996EP0729459A1 Phenyl-alkyl imidazoles as h3-receptor antagonists
09/04/1996EP0729455A1 Indole-derived azylpiperazines as ligands for 5ht1-like receptors 5ht1b and 5ht1d
09/04/1996EP0729358A1 Transdermal prostaglandin composition
09/04/1996EP0729356A1 Use of nitric oxide synthase inhibitors in the treatment of autoimmune diseases
09/04/1996EP0729354A1 Farnesyl derivatives and pharmaceutical compositions containing them
09/04/1996EP0729352A1 Interdigitation-fusion liposomes containing arachidonic acid metabolites
09/04/1996EP0729325A1 Osteogenic product and process
09/04/1996EP0644181B1 Amino acid derivative and use thereof
09/04/1996EP0355131B1 Acyl deoxyribonucleoside derivatives and uses thereof
09/04/1996CN1130354A Compositions containing amino acid salt of propionic acid non-steroidal anti-inflammatory agent and at least one of decongestant an expectorant, an antihistamine and an antitussive
09/04/1996CN1130188A Salt of phosphonocarboxyl sulfonate zoomaricoene synthetic inhibitor and method
09/04/1996CN1130184A New Tricyclic amide compounds, processes for their preparation and the pharmaceutical compositions which contain them
09/04/1996CN1130064A Solid medicinal composition containing ecipient capable of combining water
09/04/1996CN1130063A Estogen effect promoting medicine
09/04/1996CA2170844A1 Pharmaceutical compositions containing dinoreburnamenine derivatives
09/03/1996US5552536 DNA encoding precursor of interleukin-1 beta converting enzyme - related cysteine proteinase III (ice rel-III)
09/03/1996US5552520 Such as somatostatin analogs or bombesin analogs
09/03/1996US5552438 Compounds useful for treating allergic and inflammatory diseases
09/03/1996US5552437 Bisarylcarbinol derivatives as inhibitors of leukotriene biosynthesis
09/03/1996US5552435 Benzopyran and related LTB antagonists
09/03/1996US5552424 Isoxazolines as antiinflammatory agents
09/03/1996US5552422 Aryl substituted 5,5 fused aromatic nitrogen compounds as anti-inflammatory agents
09/03/1996US5552415 Cognition activators
09/03/1996US5552405 Substituted pyrrolidine derivatives as HIV protease inhibitors
09/03/1996US5552404 Compounds for neurotransmitters for animals
09/03/1996US5552401 2-benzyl-3-arylbenzothiophenes
09/03/1996US5552400 Inhibitors of protease activity
09/03/1996US5552398 Treatment of irritable bowel diarrhea
09/03/1996US5552396 Bis-indolemaleimide macrocyclic derivatives,
09/03/1996US5552384 Antiherpes compositions and method of use
09/03/1996US5552157 Quaternary ammonium lipids
08/1996
08/29/1996WO1996026279A1 Human dnase i variants
08/29/1996WO1996026272A1 Prostate-specific membrane antigen and uses thereof
08/29/1996WO1996026267A1 Viral preparations, vectors, immunogens, and vaccines
08/29/1996WO1996026205A1 Inhibitors of microsomal triglyceride transfer protein and method
08/29/1996WO1996026195A1 Benzothiazine dioxides as endothelin antagonists
08/29/1996WO1996026183A1 1-aryl-2-acylamino-ethane compounds and their use as neurokinin especially neurokinin 1 antagonists
08/29/1996WO1996025936A1 2,6-diaryl pyridazinones with immunosuppressant activity
08/29/1996WO1996025935A1 Method of treating adenosine depletion
08/29/1996WO1996025931A2 Use of fused benzothiazoles as neuroprotectants
08/29/1996WO1996025920A1 Cosmetic melanins
08/29/1996WO1996025861A1 Amino acid compositions and use thereof in clinical nutrition
08/29/1996WO1996019580A3 Telomerase protein component
08/29/1996WO1996014412A3 cDNA ENCODING A BMP TYPE II RECEPTOR
08/29/1996CA2213610A1 Ingap protein involved in pancreatic islet neogenesis
08/29/1996CA2213135A1 2,6-diaryl pyridazinones with immunosuppressant activity
08/29/1996CA2212846A1 Prostate-specific membrane antigen and uses thereof
08/29/1996CA2212525A1 Use of fused benzothiazoles as neuroprotectants
08/29/1996CA2211743A1 Viral preparations, vectors, immunogens, and vaccines
08/29/1996CA2211027A1 Benzothiazine dioxides as endothelin antagonists
08/29/1996CA2210499A1 Amino acid compositions and use thereof in a clinical nutrition
08/29/1996CA2170337A1 Naphthyl compounds, intermediates, compositions, and methods
08/29/1996CA2169414A1 Phosphorous-containing benzothiophenes
08/28/1996EP0728759A1 Heterocyclic compounds
08/28/1996EP0728746A1 Azepinone compounds useful in the inhibition of ACE and NEP
08/28/1996EP0728739A1 Biaromatic amide derivatives, pharmaceutical and cosmetic compositions containing them and their utilisations
08/28/1996EP0728738A1 Tetralinyl- and indanyl-ethylamides having melatonergic activity
08/28/1996EP0728482A2 Use of hcp specific compounds to enhance erythropoiesis
08/28/1996EP0728144A1 Peptidyl compounds and their therapeutic use as inhibitors of metalloproteinases
08/28/1996EP0728143A1 Oncoprotein protein kinase
08/28/1996EP0728142A1 Novel antler-derived bone growth factors
08/28/1996EP0728128A1 Substituted phenyl compounds
08/28/1996EP0728013A1 Compositions and method for stimulating antibody release by b lymphocytes
08/28/1996EP0728011A1 Growth factor compositions, preparation and use
08/28/1996EP0728009A1 Use of an agent which modulates tyrosine phosphorylation for modulating the permeability of a psychological barrier
08/28/1996EP0728006A1 Use of mannose phosphates for the treatment of fibrotic disorders
1 ... 1362 1363 1364 1365 1366 1367 1368 1369 1370 1371 1372 1373 1374 1375 1376 1377 1378 1379 1380 1381 1382 ... 1564